The blood pressure measurement—revisited
- 30 September 2006
- journal article
- editorial
- Published by Elsevier BV in American Heart Journal
- Vol. 152 (3), 417-419
- https://doi.org/10.1016/j.ahj.2006.03.016
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Benefits from angiotensin-converting enzyme inhibitor ‘beyond blood pressure lowering’: beyond blood pressure or beyond the brachial artery?Journal Of Hypertension, 2005
- Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With AtenololCirculation, 2004
- Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjectsJournal Of Hypertension, 2004
- Effect of different antihypertensive drug classes on central aortic pressureAmerican Journal of Hypertension, 2004
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 2002
- Central Pulse Pressure and Mortality in End-Stage Renal DiseaseHypertension, 2002
- Improvement in Blood Pressure, Arterial Stiffness and Wave Reflections With a Very-Low-Dose Perindopril/Indapamide Combination in Hypertensive PatientHypertension, 2001
- Pulsatility of ascending aortic blood pressure waveform is associated with an increased risk of coronary heart disease.American Journal of Hypertension, 2001
- Blood pressure measuring devices: recommendations of the European Society of HypertensionBMJ, 2001
- Pulsatility of ascending aortic pressure waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty.Circulation, 2000